Impact of Steroid-Induced Diabetes on Prognosis of Patients with Aggressive Lymphoid Malignancies: A Prospective Study

Impact of body mass index and leptin on response of non-Hodgkin's lymphomas to chemotherapy

Biochemical Alteration and Immunohistochemical Characterization of Lymphoid Cells Involved in Type 2 Diabetes Mellitus

Relapse in Patients with Non-Hodgkin’s Lymphpma

Endocrinopathies as a price of cancer treatment

Long Term Outcomes of Relapsed/Refractory Non-Hodgkin Lymphoma:
A Single Center Experience

The Influence of Serum Leptin Level and Body Mass Index on the Prognosis of Patients with Diffuse Large B Cell Lymphoma

Hodgkin Lymphoma: A Retrospective Clinical and Pathological Analyses with Correlation to Treatment Outcome

Liposomal Doxorubicin based Chemotherapy in the treatment of Relapsed Diffuse Large B-cell Lymphoma

Effect of experimentally induced diabetes mellitus on serum leptin level and the role of insulin replacement therapy